Professor Julian Jack FRS, FMedSci, FRCP
Professor Jack was Professor of Physiology, University of Oxford from 1996-2003, and a Governor of the Wellcome Trust from 1987-2003 (Deputy Chairman of the Governors from 1994-99). He is distinguished for his outstanding theoretical and experimental contributions to the understanding of synaptic transmission in the central nervous system.
Sir Tom Blundell FRS FMedSci
Tom Blundell has been Sir William Dunn Professor of Biochemistry at the University of Cambridge since 1995, and from 1 October 2003 Chairman of the Council of Biological Sciences in Cambridge. His research is focused on structural biology of cell regulation, structural bioinformatics and applications to drug discovery and medicine. After research and teaching positions in Molecular Biophysics in Oxford and Biochemistry in Sussex Universities, he was appointed in 1976 Professor in Birkbeck College, University of London and in 1989 Honorary Director, Imperial Cancer Research Fund Unit of Structural Molecular Biology. Tom Blundell is a member of Academia Europ
Tom Blundell has played an active role in national science policy. In the 1980s, he was a member of the advisory group to the Prime Minister (ACOST). He was Director General, Agricultural and Food Research Council (1991 1994) and founding Chief Executive, Biotechnology and Biological Sciences Research Council, BBSRC (1994-1996). He was Chairman of the Royal Commission on Environmental Pollution, 1998 to 2005. He has been President of the UK Biosciences Federation since 2004. He co-founded Astex Therapeutics which has oncology drugs in early stage clinical trials in USA and UK. He was a Non-Executive Director of Celltech from 1996 to 2005 and has been involved in science advisory roles with Pfizer, UCB and SmithKlyneBeecham.
Professor Peter Goodfellow
Professor Goodfellow has worked for many years as a research scientist specialising in human genetics. His first independent position was at the Imperial Cancer Research Fund in London, where he worked for 13 years studying human gene mapping and the genetics of sex determination. In 1992, he was elected to the position of Balfour Professor of Genetics at Cambridge University. For the past decade, Peter worked in the pharmaceutical industry, serving as head of Discovery for SmithKline Beecham and Senior Vice-President of Discovery Research at GlaxoSmithKline.
Amongst other honours, Peter has been elected as a Fellow of The Royal Society and has been awarded the Louis Jeantet Prize for Medicine (with Dr R Lovell-Badge), the Francis Amory Prize (with Dr R.Lovell-Badge) and a Doctorate in Science (honoris causa) from Bristol University.